Profil
April Manness formerly worked at Luminor Medical Technologies, Inc., as Chief Financial Officer, Luminor Medical Technologies, Inc., as Chief Financial Officer in 2011, Kane Biotech, Inc., as Interim Chief Financial Officer from 2011 to 2012, and DiaMedica Therapeutics, Inc., as Chief Financial Officer.
Anciens postes connus de April Manness
| Sociétés | Poste | Fin |
|---|---|---|
| KANE BIOTECH INC. | Directeur Financier/CFO | 01/01/2012 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Directeur Financier/CFO | 23/12/2011 |
| DIAMEDICA THERAPEUTICS INC. | Directeur Financier/CFO | - |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Directeur Financier/CFO | 17/10/2007 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| KANE BIOTECH INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
